INTRODUCTION
The oral route is considered as the most promising route of drug delivery. Effective oral drug delivery may depend upon the factors such as gastric emptying process, gastrointestinal transit time of dosage form, drug release from the dosage form and site of absorption of drugs
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. Floating multiparticulate are gastro-retentive drug delivery systems based on non-effervescent and effervescent approach. Hollow microspheres are in strict sense, spherical empty particles without core. These microspheres are characteristically free flowing powders consisting of proteins or synthetic polymers, ideally having a size less than 200 micrometer.
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Gastroretentive systems can remain in the gastric region for several hours and hence significantly prolong the gastric residence time of drugs. Prolonged gastric retention improves bioavailability, reduces drug waste, and improves solubility for drugs that are less soluble in a high pH environment. 4 It is a formulation of a drug with gel forming hydrocolloids meant to remain buoyant in the stomach contents. Drug dissolution and release from the dosage form retained in the stomach fluids occur at the pH of the stomach under fairly controlled conditions
5
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SUITABLE DRUG CANDIDATES FOR GASTRO RETENTION 6
In general, appropriate candidates for gastroretentive dosage form are molecules that have poor colonic absorption but are characterized by better absorption properties at the upper parts of the GIT:
 Narrow absorption window in GI tract, e.g., riboflavin and levodopa Non-effervescent floating dosage forms use a gel forming or swellable cellulose type hydrocolloids, polysaccharides, and matrix forming polymers like polycarbonate, polyacrylate, polymethacrylate, and polystyrene. The formulation method includes a simple approach of thoroughly mixing the drug and the gelforming hydrocolloid. After oral administration this dosage form swells in contact with gastric fluids and attains a bulk density of < 1. The air entrapped within the swollen matrix imparts buoyancy to the dosage form. The so formed swollen gel-like structure acts as a reservoir and allows sustained release of drug through the gelatinous mass. Excipients used most commonly in these systems include hydroxypropyl methyl cellulose (HPMC), polyacrylate polymers, polyvinyl acetate, Carbopol, agar, sodium alginate, calcium chloride, polyethylene oxide and polycarbonate
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B. Multiple Unit Floating Dosage Systems
Multiple unit dosage forms may be an attractive alternate since they have been shown to reduce inter and intra-subject variabilities in drug absorption as well as to lower the possibility of dose dumping. Various multiple unit floating systems have been developed in different forms, and using principles such as air compartment multiple unit system, hollow microspheres prepared by emulsion solvent diffusion method, beads prepared by emulsion gelation method. Use of effervescent and swellable polymer is another approach for preparing multiple unit FDDS 10 .
a) Effervescent Systems
A multiple unit system comprises of calcium alginate core and calcium alginate/PVA membrane, both separated by an air compartment was prepared. In presence of water, the PVA leaches out and increases the membrane permeability, maintaining the integrity of the air compartment. Increase in molecular weight and concentration of PVA, resulted in enhancement of the floating properties of the system. Freeze-drying technique is also reported for the preparation of floating calcium alginate beads. Sodium alginate solution is added drop wise into the aqueous solution of calcium chloride, causing the instant gelation of the droplet surface, due to the formation of calcium alginate. The obtained beads are freeze-dried resulting in a porous structure, which aid in floating. The authors studied the behavior of radiolabeled floating beads and compared with nonfloating beads in human volunteers using gamma scintigraphy. Prolonged gastric residence time of more than 5.5 h was observed for floating beads. The nonfloating beads had a shorter residence time with a mean onset emptying time of 1 hr 11 . 
c) Non-effervescent Systems
No much report was found in the literature on effervescent multiple unit systems, as compared to the effervescent systems. However, few workers have reported the possibility of developing such system containing indomethacin, using chitosan as the polymeric excipient. A multiple unit HBS containing indomethacin as a model drug prepared by extrusion process is reported. A mixture of drug, chitosan and acetic acid is extruded through needle, and the extrudate is cut and dried. Chitosan hydrates and floats in the acidic media, required drug release could be obtained by modifying the drug-polymer ratio
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d) Hollow Micro spheres
Hollow microspheres loaded with drug in their outer polymer shelf were prepared by a novel emulsion solvent diffusion method. The ethanol/dichloromethane solution of the drug and an enteric acrylic polymer was poured into an agitated solution of Poly Vinyl Alcohol (PVA) that was thermally controlled at 400C. The gas phase is generated in the dispersed polymer droplet by the evaporation of dichloromethane formed and internal cavity in the microsphere of the polymer with drug. The microballoon floated continuously over the surface of an acidic dissolution media containing surfactant for more than 12 hrs
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Figure 3: Formulation of floating microspheres C. Raft forming system
Here, a gel-forming solution (e.g. Sodium alginate solution containing carbonates or bicarbonates) swells and forms a viscous cohesive gel containing entrapped CO2 bubbles on contact with gastric fluid. Formulations also typically contain antacids such as aluminium hydroxide or calcium carbonate to reduce gastric acidity. Because raft forming systems produce a layer on the top of gastric fluids, they are often used for gastrooesophageal reflux treatment
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MECHANISM OF FLOATING SYSTEMS
Floating drug delivery systems (FDDS) have bulk density lesser than gastric fluids, so they remain buoyant in the stomach without affecting the gastric emptying rate for a prolonged period of time. While the system is floating on the gastric contents, the drug is released slowly at the desired rate from the system. However, besides a minimal gastric content needed to allow the proper achievement of the buoyancy retention principle, a minimal level of floating force (F) is also required to keep the dosage form reliably buoyant on the surface of the meal. To measure the floating force kinetics, a novel apparatus for determination of resultant weight has been reported in the literature. The apparatus operates by measuring continuously the force equivalent to F (as a function of time) that is required to maintain the submerged object. This apparatus helps in optimizing FDDS with respect to stability and durability of floating forces produced in order to prevent the drawbacks of unforeseeable intragastric buoyancy capability variations 17 .
ADVANTAGES OF FLOATING DRUG DELIVERY SYSTEMS
Floating dosage systems form important technological drug delivery systems with gastric retentive behavior and offer several advantages in drug delivery. These advantages include:
1. FDDS can remain in the stomach for several hours and therefore prolong the gastric retention time of various drugs 5. Bioavailability enhances despite first pass effect because fluctuations in plasma drug concentration are avoided; a desirable plasma drug concentration is maintained by continuous drug release 20 .
6. Acidic substance like aspirin causes irritation on the stomach wall when come in contact with it hence; HBS/FDDS formulations may be useful for the administration of aspirin and other similar drugs.
7. The FDDS are advantageous for drugs absorbed through the stomach eg: Ferrous salts, Antacids. Improved drug absorption, because of increased GRT and more time spent by the dosage form at its absorption site.
8. Site-specific drug delivery 21 .
LIMITATIONS OF GASTRORETENTIVE DRUG DELIVERY SYSTEMS
1. Drugs which are irritating the gastric mucosa are also not suitable.
2. The drug substances that are unstable in the acidic environment of the stomach are not suitable candidates to be incorporated in the systems.
3. Not suitable for drugs that have solubility or stability problem in GIT
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4. The drugs that are significantly absorbed through out gastrointestinal tract, which undergo significant first pass metabolism, are only desirable candidate 23 .
5. The ability to float relies on the hydration state of the dosage form. In order to keep these tablets floating, intermittent administration of water is beneficial 24 .
EVALUATION OF FLOATING DRUG DELIVERY SYSTEMS
1. Determination of hardness of tablet:-Randomly sampled twenty tablets in each batch of formulations should be used for the determination of hardness with the help of Monsanto type hardness tester
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Determination of weight variation:-Twenty tablets
selected at the random are weighed accurately and the average weight of the tablet is calculated. Then the deviation of individual weight from the average weight is calculated.
Determination of thickness of the tablet:-
The individual crown to crown thickness of ten tablets is determined using slide calipers for each batch
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Floating lag time:
It is the time taken by the tablet to emerge on to the surface of dissolution medium and is expressed in seconds or minutes
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. 
Measurement of Floating

Angle of repose:-
The frictional forces in a loose powder or granules can be measured by angle of repose. This is the maximum angle possible between the surface of a pile of powder or granules and the horizontal plane.
The granules were allowed to flow through the funnel fixed to a stand at definite height (h). The angle of repose was then calculated by measuring the height and radius of the heap of granules formed 
Determination of In Vitro Dissolution Study
The test for buoyancy and in vitro drug release studies are usually carried out in simulated gastric and intestinal fluids maintained at 37 o C. In practice, floating time is determined by using the USP dissolution apparatus containing 900ml of 0.1 HCl as a testing medium maintained at 37 o C. The time required to float the HBS dosage form is noted as floating (or floatation) time
30
CONCLUSION
Drug absorption in the gastrointestinal tract is a highly variable procedure and prolonging gastric retention of the dosage form extends the time for drug absorption. Drug absorption in the gastrointestinal tract is a highly variable process and prolonging gastric retention of the dosage form extends the time for drug absorption. Thus gastro retentive dosage forms provide an additional advantage for drugs that are absorbed primarily in the upper segments of gastrointestinal tract.
